Together 4 Cancer Comapass

Together4Cancer Compass

For community oncology leaders who lead by clarity guided by evidence and empathy.

One insight per issue. Clear. Actionable. Rooted in real-world impact.

Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss

You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…

Continue ReadingGermline Testing: The Therapeutic Biomarker You Can’t Afford to Miss

Not Just Another Update

Clinic

Built for clinicians. Backed by data.

Automated

Actionable insights. Practice-ready relevance.

Credible

De-branded by design. Clear, credible - built to drive action.

Because breakthroughs shaping cancer care deserve more than attention. They deserve action.